|
Sun Pharma Advanced Research Company Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
5225.45 Cr.
|
P/BV
|
-67.53
|
Book Value (Rs.)
|
-2.38
|
|
52 Week High/Low (Rs.)
|
241/109
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2020
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 44.58 | 58.99 |
| Total Income From Operations | 44.58 | 58.99 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 17.42 | 20.67 |
| Employees Cost | 123.73 | 91.81 |
| Depreciation | 9.44 | 9.44 |
| Other Expenses | 173.39 | 242.78 |
| Total Expenses | 323.98 | 364.70 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -279.40 | -305.71 |
| Other Income | 1.79 | 25.07 |
| P/L Before Interest, Excpt. Items & Tax | -277.61 | -280.64 |
| Interest | 4.50 | 0.78 |
| P/L Before Exceptional Items & Tax | -282.11 | -281.42 |
| P/L Before Tax | -282.11 | -281.42 |
| Tax | 0.63 | 0.00 |
| P/L After Tax from Ordinary Activities | -282.74 | -281.42 |
| Net Profit/Loss For the Period | -282.74 | -281.42 |
| Net P/L After Minority Interest & Share Of Associates | -282.74 | -281.42 |
| | | |
| Equity Share Capital | 32.45 | 32.45 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | -8.71 | -8.67 |
| Diluted EPS (Rs.) | (8.71) | -8.67 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | -8.71 | -8.67 |
| Diluted EPS (Rs.) | (8.71) | -8.67 |
| | | |
| PBITOE Margin (%) | -626.73 | -518.24 |
| PBTE Margin (%) | -632.81 | -477.06 |
| PBT Margin (%) | -632.81 | -477.06 |
| PAT Margin (%) | -634.23 | -477.06 |
| PAT After MI And SOA Margin (%) | -634.23 | -477.06 |
